Following Trump's tariff pause in April 2025, the Nifty Healthcare index rebounded strongly, rising 7%. Mutual funds increased holdings in several healthcare stocks, with Syngene International seeing ...

Investec initiated coverage on Eris Lifesciences with a buy rating and a target price of Rs 1,880. Eris is poised for a ...